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Methods/materials: Databases such as the PubMed, and Google Scholar were
utilized to find current and relevant findings for this reviewed literature. Mendeley
was utilized to gather and store findings. The following keyword search items
include probiotics, oral health, periodontal diseases, periodontitis, dental caries,
gingivitis, halitosis, Lactobacilli, and biotherapy. Articles were narrowed down to
include studies published within the last 5 years.
Results: Short-term clinical studies suggest that the oral intake of probiotics show
a strong inhibitory effect on the growth and biofilm formation of pathogenic strains,
stimulate the immune function, and regulate the inflammatory response. Their
repeated success in inhibiting harmful oral bacteria suggests that the use of
probiotics holds a promising future in dentistry.
Conclusion: Although still in its initial stages, the use of probiotics is being
established as a living biotherapeutic designed to restore normal oral microflora in
the oral cavity. More long-term clinical trials are needed to fully understand their
functioning and substantiate their role in oral health.

Introduction
Probiotics has been defined by the World Health Organization (WHO) as “live
microorganisms which when administered in adequate amounts, confer benefits
to the health of the host.” Their use has been increasingly substantiated due to
the slow process of antibiotic production and the growing spread of antibiotic
resistance plaguing healthcare systems and communities worldwide 6.
The use of living therapeutics has made its mark in the field of general medicine,
where research of bacterial strains such as Bifidobacteria and Lactobacilli has
progressed to biotherapeutic treatments managing conditions such as
inflammatory bowel disease, vaginal infections, and respiratory tract infections
1,7,8. Research suggests that these same bacterial strains show considerable
promise in inhibiting the growth of Streptococci and Candida species 9.
The oral cavity contains an intricate population of diverse bacterial species with a
healthy adult harboring a vast network of 700 predominant bacterial strains
covering the tongue, cheeks, gingiva, palate and surrounding tissues where
Streptococci, viruses and fungi form about 20% of this population1. These
microbial communities are built upon synergistic and antagonistic interactions, cell
to cell signaling, and gene transfer giving biofilms their structurally sound
resistance to chemical interactions mediated by the neutralizing effect of saliva,
contributing to our oral health 2,3.
The triggering of homeostasis to dysbiosis is influenced by the pH fluctuations that
create environmental conditions favoring acid tolerant bacterial species such as S.
mutans, P. gingivalis, and P. intermedia giving way to several oral diseases
including periodontitis and gingivitis 3,4. In recent years, the use of antimicrobial
capabilities of probiotics are being explored to combat the effects of pathogenic
bacteria residing in the oral cavity, relying on the hypothesis that commensal
bacteria can re-establish a neutral environment 5. This review of literature
underlines the possible therapeutic and preventative role of probiotics against the
development of oral diseases.

Discussion

Results

Abstract

Introduction: Probiotics are widely known for their health promoting benefits,
especially with its association to gastrointestinal health. For many years, most
research has primarily focused on the prevention or treatment of gastrointestinal
infections or diseases. However, recently probiotics has been a subject of
investigation with its association to oral health. This review of literature is designed
to analyze the effectiveness of using probiotics as a preventative and therapeutic
method for oral infections/diseases such as periodontitis, dental caries, and the
like.
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Results From the Studies Reviewed
Author/Year

Patients

Treatment

Probiotic
strain/Vehicle

Though the mechanism of probiotics is not clearly established, probiotic strains
such as Lactobacilli may play an important role in the maintenance and balance of
indigenous microflora in the oral cavity. It has been suggested that the mode of
action through which probiotics stimulate the immune function and regulate the
inflammatory response involves:
• pH modification via organic acids
• Antagonistic effects on pathogens through production of bacteriostatic
substances such as bacteriocins and proteins
• Impediment of adhesion and subsequent biofilm formation of pathogenic
bacterial strains.
In addition, studies also emphasize that probiotic bacterial strains can exert
differing effects based upon various environmental factors such as the type of
pathogen present, or salivary components17-19.These findings potentially reveal the
immunological effects directed by the probiotic bacterial strains on the oral mucosa
which includes 21:
• Increased IgA antibody production
• Increased microphage activity
• Rise in phagocytotic activity
It is important to highlight that several of the studies utilized pretreatment
procedures such as SRP or adult prophylaxis before the administration of
probiotics10-14. Probiotic use in concurrence with nonsurgical periodontal therapy
and preventative care may ensure a more consistent response in respect to longterm probiotic use to treat chronic diseases such as periodontitis and gingivitis.
The effectiveness of probiotic use depends on a variety of factors including the
type of probiotic bacterial strains, and the conditions present within the host 9.
Current findings on the potential benefits gained from the use of probiotics in the
oral cavity is encouraging, but more consistent clinical research is needed to
establish probiotics as a prevention and treatment method towards oral infections.

Conclusions

Morales et al.
2016

28 periodontal
patients w/ 4
smokers (2
placebos)

Periodontitis - 1x daily for
3 months and monitored
3,6,9,12 months after
deadline after SRP

Lactobacillus
rhamnosus via
sachet

Reduction in pocket
depths after 1 year follow
up

Iwasaki et al.
2016

19 (unspecified)
test group (17
placebos)

Periodontitis - 1x daily for
12 weeks

L. plantarum via Reduction in pocket
capsule
depths

Alok et al.
2017

Periodontal
patients

Periodontitis - Absorb
probiotic through lozenge
for 4 days

L. brevis via
lozenges

Grusovin et al.
2019

20 patients (10
placebos)

Periodontitis L. reuteri via
Administrations of L.
lozenges
reuteri lozenges 2x daily
monitored 3,6,9,12 months

Pocket depth reduction
and attachment gain
within 6 months, BOP
reduction at 6 to 9
months

Montero et al.
2017

59 patients (30
placebos)

Gingivitis - 2 oral tablets
daily

L. plantarum, L.
brevis,
Pediococcus
acidilactici via
tablets

Reduction in pathogenic
bacterial strain T.
forsythia, no significant
changes in GI indices

Alkaya et al.
2016

40 healthy
patients, 18-31
years, (20
placebos)

Gingivitis - Probiotic
toothpaste and mouth
rinse for a period of 8
weeks along with adult
prophylaxis treatments for
3 weeks

Bacillus subtilis,
bacillus
megaterium,
bacillus pumilus
via toothpaste
and mouth rinse

Plaque and gingival
indices reduced, no
significant differences
between test and
placebo groups

Lin et al.
2017

18 patients (7-11
years)

Gingivitis - Consume
Lactobacillus
Yakult, probiotic beverage, casei via
for 7 days
probiotic
beverage

Increase in pH,
significant cariostatic
effects on oral biofilm
acidogenicity

Benic et al.
2019

Orthodontic
patients

Halitosis - 2 lozenges for 1 Streptococcus
month with a 3-month
salivarus via
follow-up
lozenges

Reduced levels of
halitosis with no
significant changes in
plaque and gingival
indices and dental
biofilm microflora.

Reduction in
inflammation, BOP,
plaque and GI indices

Graph 1. Results from the published studies discussed in this review investigate the impact of
probiotics on oral health utilizing various bacterial strains through multiple vehicles of
administration 12-18. The studies focus on the interaction between pathogenic bacterial strains
and probiotics as a form of biotherapeutic treatment targeting periodontitis, gingivitis, halitosis,
and dental caries. Most of the studies in this review demonstrate a reduction in pocket depths,
plaque and GI indices, BOP, CAL, and inflammation.

Conclusions & Future Research
Research is currently being conducted to target these obstacles, expanding
towards the potential use of probiotics tailor-made to deliver treatment to the oral
microflora of the individual, maximizing precision and site specificity 22.These
studies need to be conducted in larger populations including long observation
periods. With an increasing dilemma of antibiotic resistance contributing to the
ineffective treatment of microbial diseases, probiotics as a means of biotherapy
appears to be a new approach for the prevention of oral infections.
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Abstract
Introduction: Probiotics are widely known for their health promoting benefits, especially with
its association to gastrointestinal health. For many years, most research has been focused on the
prevention or treatment of gastrointestinal infections or diseases. However, recently probiotics
has been a subject of investigation with its association to oral health. This review of literature is
designed to analyze the effectiveness of using probiotics as a preventative and therapeutic
method for oral infections/diseases such as periodontitis, dental caries, and the like.
Methods: Databases such as the PubMed, and Google Scholar were utilized to find current and

relevant findings for this reviewed literature. Mendeley was utilized to gather and store findings.
Following keyword search items include probiotics, oral health, periodontal diseases,
periodontitis, dental caries, gingivitis, halitosis, Lactobacilli, and biotherapy. Articles were
narrowed down to include studies published within the last 5 years.
Results: Short-term clinical studies suggest that the oral intake of probiotics show a strong
inhibitory effect on the growth and biofilm formation of pathogenic strains, stimulate the
immune function, and regulate the inflammatory response. Their repeated success in inhibiting
harmful oral bacteria suggests that the use of probiotics holds a promising future in dentistry.
Conclusion: Although still in its initial stages, the use of probiotics is being established as a
living biotherapeutic designed to restore normal oral microflora in the oral cavity. More longterm clinical trials are needed to fully understand their functioning and substantiate their role in
oral health.
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Introduction
The human microbiome is an incredibly complex structure encompassing a diverse
community of microorganisms including bacteria, fungi, and viruses. The oral cavity alone
contains an intricate population of diverse bacterial species with a healthy adult harboring as
many as 100 billion bacteria (1). This vast network of bacterial composition has been estimated
to be comprised of 700 predominant bacterial species covering the tongue, cheeks, gingiva,
palate and surrounding tissues where Streptococci, viruses and fungi form about 20% of this
population (2). These microbial communities are built upon synergistic and antagonistic
interactions, cell to cell signaling, and gene transfer giving biofilms their structurally sound
resistance to chemical interactions mediated by the neutralizing effect of saliva, contributing to
our oral health (3,4).
The triggering of homeostasis to dysbiosis is influenced by the pH fluctuations that create
environmental conditions favoring acid tolerant bacterial species such as S. mutans, P. gingivalis,
and P. intermedia giving way to several oral diseases including periodontitis and gingivitis (4,5).
In recent years, the use of antimicrobial capabilities of probiotics are being explored to combat
the effects of pathogenic bacteria residing in the oral cavity, relying on the hypothesis that
commensal bacteria can re-establish a neutral environment (6).
For the past 20 years, there has been a surge in interest focused on the promising effects
of probiotics. Probiotics has been defined by the World Health Organization as “live
microorganisms which when administered in adequate amounts, confer benefits to the health of
the host.” Their use has been increasingly substantiated due to the slow process of antibiotic
production and the growing spread of antibiotic resistance plaguing healthcare systems and
communities worldwide (7).
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The use of living biotherapeutics has made its mark in the field of general medicine,
where research of bacterial strains such as Bifidobacteria and Lactobacillus has progressed to
treatments managing conditions such as inflammatory bowel disease, vaginal infections, and
respiratory tract infections (2,8,9). Research has suggested that these same bacterial strains have
shown considerable promise in inhibiting the growth of Streptococci and Candida species (10).
This review of literature underlines the possible therapeutic and preventative role of probiotics
against the development of oral infections.
Methods
Databases such as the PubMed and Google Scholar were utilized to find current and
relevant findings for this reviewed literature. Mendeley was utilized to gather and store findings.
The following keyword search items include probiotics, oral health, periodontal diseases,
periodontitis, dental caries, gingivitis, halitosis, Lactobacilli, and biotherapy. Articles were
narrowed down to include studies published within the last 5 years.
Results
Periodontitis
Chronic periodontitis is an inflammation of the tissue surrounding the teeth, causing gum
recession and destruction of the alveolar bone (10). Main bacteria associated with this disease are
P. gingivalis, T. denticola, and T. forsythia (11).
Morales et al. conducted a study where they evaluate the clinical effects of the probiotic
strain, Lactobacillus rhamnosus, in a non-surgical treatment of chronic periodontitis patients.
(12). Twenty-eight volunteers with an equal proportion of male and female participated in this
study. Four smokers were in the test group, while two were in the control group. Individuals
received non-surgical therapy, such as scaling and root planing (SRP), and were randomly
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assigned to a test (probiotic sachet containing L.rhamnosus SP1) or control (placebo) group. The
test group administered the probiotic sachet once a day for 3 months, starting after the last
session of SRP. Volunteers were monitored clinically at baseline and 3, 6, 9, 12 months after
therapy. Main clinical parameters measured included BOP, plaque accumulation, probing depths
(PDs), and clinical attachment loss (CAL). Upon evaluation, both test and control groups showed
improvements in the clinical parameters measured. However, the test group showed significant
reductions of PD than the control group. Also, after following up for 1 year, the results revealed
a significant reduction in the number of individuals with pocket depths (PD) that were > 6mm, in
contrast to the placebo group. Researchers concluded that administering L.rhamnosus SP1
resulted in similar clinical improvements compared with SRP alone (12).
Another similar study was conducted where an oral administration of heat-activated L.
plantarum L-137 (HK L-137) was evaluated with respect to periodontal therapy outcome (13).
This randomized, double-blind, placebo-controlled clinical trial included 39 patients (24 women
and 15 men, mean age 66.2 years) divided into two groups (19 in the test group and 17 patients
control groups). Test group received the HK L-137 capsule (10 mg) or the placebo capsule daily
for 12 weeks. Clinical parameters include plaque and gingival indices, bleeding on probing
(BOP), probing depth (PD) which were scored at baseline and 4, 8, and 12 weeks prior to
prophylaxis together with supportive periodontal therapy visits. The study results indicate that
daily intake of HK L-137 can reduce periodontal pocket depths in patients undergoing supportive
periodontal therapy (13).
Another study evaluated the effect of L. brevis in the treatment of patients suffering from
chronic periodontitis (10). Participants who have chronic periodontitis were asked to suck
L.brevis-contained lozenges for a period of 4 days. The following results showed improved
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clinical parameters (i.e. plaque and gingival indices and bleeding on probing) for all patients with
significant salivary level reduction of prostaglandin E2 (PGE2) and matrix metalloproteinases
(MMPs). The authors in this study emphasized that the anti-inflammatory effect of L.brevis
could be due to a number of specific enzymes, aiding the prevention of producing nitric oxide;
eventually stopping the release of PGE2 and MMP activation (10).
Grusovin et al. conducted a double-blind, randomized placebo-controlled pilot study to
evaluate the efficacy of L.reuteri probiotic therapy with generalized stage III and IV periodontitis
patients (14). This trial was conducted for 12 months with measurements being obtained every 3
months. A total of twenty patients were randomly divided into two equal groups. The test group
received administrations of L.reuteri-contained lozenges twice a day, while the control one
received a placebo. Outcome measures were probing periodontal pockets (PPD), probing
attachment level (PAL), and bleeding on probing (BOP). Complications, tooth loss, and tooth
survival were recorded as well. At the end of the 1-year period, the results showed some
improved clinical outcomes. The test group (probiotic group) were found to have PPD reduction
and PAL gain in 6 months and more BOP reduction at 6 and 9 months. The authors in this study
suggested oral administration of L.reuteri probiotic lozenges could be considered as a useful
supplement in the maintenance therapy of GPIII-IV patients (14).

Gingivitis
Montero et al. conducted a study to evaluate the effectiveness of a probiotic combination
in treating gingivitis and assessing its effect on the subgingival microbiota. This placebocontrolled clinical trial was conducted for a period of 6 weeks involving a total of 59 patients (29
tests and 30 placebos). The test treatment consisted of taking two oral tablets per day containing
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the combination of probiotic strains—Lactobacillus plantarum, Lactobacillus brevis, and
Pediococcus acidilactici. The control group received the same tablets, but without the live
bacterial strain. Outcome measures were changes in GI, collection and analysis of subgingival
samples by quantitative polymerase chain reaction (qPCR) for five presumed periodontal
pathogens. Both groups experienced statistical improvement in mean GI (p< .0001). However,
no difference was found between treatment groups for any clinical index. Results revealed in the
test group, a reduction in the number of sites with higher GI scores (GI=3 at baseline) were
significant. In subgingival samples, a remarkable reduction of T. forsythia was significant only in
the test group (p< 0.008). The authors concluded that the use of probiotic tablets did not lead to
significant changes in the mean GI, although there is a significant decrease in the number of sites
with severe inflammation (15).
A 2016 randomized, double-blind, placebo-controlled clinical trial was conducted to
evaluate the effectiveness of bacilli-containing probiotic treatment in patients with gingivitis
(16). Forty healthy patients (20 females and 20 males, aged 18-31 years) with generalized
gingivitis were randomly assigned. The patients received a pretreatment, such as supragingival
scaling and/or regular adult prophylaxis, for 3 weeks. Then, each participant in the test group (20
patients) received one toothbrush, probiotic toothpaste, two probiotic mouth rinses, and a box of
probiotic toothbrush cleaner to be used for a span of 8 weeks, while the control group received
similar placebo products. Probiotic products contained 5x107 CFU of Bacillus subtilis, Bacillus
megaterium, and Bacillus pumulus spores. Results showed that the plaque and gingival indices
were significantly reduced after the 8-week treatment, yet it did not show any statistically
significant differences between the probiotic and placebo group in terms of using the probioticcontained products (16).
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Caries
Streptococcus mutans is notably recognized as the primary causative microorganism and
significant contributor in the etiology of dental caries. Several studies were conducted to evaluate
the effect of different strains of probiotics in controlling the development of dental caries (11).
Lin et al. conducted a study to investigate the effects of Yakult intake, which is a wellknown probiotic beverage consisting of Lactobacillus casei Shirota, on oral biofilm
acidogenicity, cariogenic bacterial counts, and caries risk in children (17). Eighteen children (711 years) participated. They were instructed to consume standard Yakult daily for 7 days.
Outcome measurements include oral biofilm acidogenicity distinguished by the Stephan curve,
caries risk, and the Lactobacillus and Streptococcus mutans counts, were evaluated and
calculated. The results after intervention showed significant increase in minimum pH value and
significant cariostatic effects on oral biofilm acidogenicity. The authors concluded that shortterm Yakult intake is beneficial in promoting oral health in children with certain oral biofilm and
caries risk; however, further studies may be needed to justify or validate the efficacy of this
probiotic. At present, it did not cause adverse effects or increase risks of caries (17).

Halitosis
Halitosis, or oral malodor, is a result of Gram-negative anaerobic bacteria that breaks
down salivary and food proteins, generating amino acids, which eventually produces volatile
malodorous compounds (VCS), causing bad breath. One of the earliest probiotic strains, S.
salivarius, which helped reduce VCSs concentrations in individuals, represented as the
predominant microorganism in the tongue microbiota (11).
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A 2019 randomized, triple-blind, placebo-controlled study was conducted to evaluate the
efficacy of the oral probiotic Streptococcus salivarius M18 on oral hygiene markers and halitosis
in patients wearing orthodontic braces (18). Patients who underwent fixed orthodontic treatment
were randomly assigned to a probiotic group (n=32) and a placebo group (n=32). They
consumed 2 lozenges for one month. At the end of the intervention, assessments were taken at
baseline, with a 3-month follow-up. Outcome measures include PI, GI, and halitosis-causing
VCS levels. After analyzing the dental biofilms before and after intervention, it was found that
the plaque and gingival indices were not significantly influenced by the probiotic intervention (p
> 0.05). Yet the VCS levels had significant reduction in both the probiotic group (VCS
reduction= -8.5%, 95% CI = -7.4% to -9.1%, p=0.015) and the placebo group (-6.5%, 95% CI= 6.0% to -7.4%, p=0.039) after the 1-month intervention. However, the VCS levels in the placebo
group started back up to baseline levels compared to those in the probiotic test group, which
decreased further (-10.8%, 95% CI= -10.5% to -12.9%, p=0.005). The authors of the study
concluded that oral probiotic strain S. salivarius M18 reduced levels of halitosis in patients with
orthodontic treatment, especially those wearing braces, but had minimal effects on PI, GI, and
dental biofilm microflora (18).
Discussion
Though the mechanism of probiotics is not clearly established, probiotic strains such as
Lactobacilli may play an important role in the maintenance and balance of indigenous microflora
in the oral cavity. Results from the published studies discussed in this review investigate the
impact of probiotics on oral health utilizing various bacterial strains through multiple vehicles of
administration. The studies focus on the interaction between probiotic strains and pathogenic
bacterial strains such as S. mutans, P. intermedia, P. gingivalis and T. forsythia , which are some
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of the major etiologic agents that contribute to periodontitis, gingivitis, halitosis, and dental
caries.
It has been suggested that the mode of action through which probiotics stimulate the
immune function and regulate the inflammatory response involves pH modification via organic
acids, antagonistic effects on pathogens through production of bacteriostatic substances such as
bacteriocins and proteins, and impediment of adhesion and subsequent biofilm formation of
pathogenic bacterial strains. In addition, studies also emphasize that probiotic bacterial strains
can exert differing effects based upon various environmental factors such as the type of pathogen
present, or salivary components (19–21). Most of the studies in this review demonstrate a
reduction in pocket depths, plaque and GI indices, BOP, CAL, and inflammation (10,12,16,22).
These findings potentially reveal the immunological effects directed by the probiotic bacterial
strains on the oral mucosa which includes increased IgA antibody production, increased
microphage activity, and a rise in phagocytotic activity (23). It is important to highlight that
several of the studies utilized pretreatment procedures such as SRP or adult prophylaxis before
the administration of probiotics (12,16). Probiotic use in concurrence with nonsurgical
periodontal therapy and preventative care may ensure a more consistent response in respect to
long-term probiotic use to treat chronic diseases such as periodontitis and gingivitis.
Although none of the studies in this review presented with adverse effects, there are
major concerns that any probiotic-mediated treatment could induce immune function that could
potentially lead to acute inflammatory responses, harmful metabolic activities, and an overly
stimulated immune response. The effectiveness of probiotic use depends on a variety of factors
including the type of probiotic bacterial strains, and the conditions present within the host (10).
Research is currently being conducted to target these obstacles, expanding towards the potential
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use of probiotics tailor-made to deliver treatment to the oral microflora of the individual,
maximizing precision and site specificity (24). The use of probiotics is still in its initial stages.
Current findings on the potential benefits gained from the use of probiotics in the oral cavity is
encouraging, but more consistent clinical research is needed to establish probiotics as a
prevention and treatment method towards oral infections.
Conclusion
Although studies have shown positive results, few limitations must be considered of these
present studies. First, there was a significant heterogeneity in the studies such as using different
strains of bacteria, and inconsistencies in the dosage and frequent intake of the probiotic per day.
Second, the number of participants or volunteers were rather small, and the observation period
was only short-term. Therefore, these studies need to be conducted in larger populations with
longer observation periods. Nevertheless, the results in these studies support the effectiveness of
oral probiotics in the oral cavity and the resulting clinical improvements, even though it was
done on a short-term period. If these preliminary results are evaluated in a larger study scale, the
practical application of probiotics could possibly be proposed in the future as a new mechanism
in preventing oral diseases. With an increasing dilemma of antibiotic resistance contributing to
the ineffective treatment of microbial diseases, probiotic as a means of biotherapy appears to be a
new approach for the prevention of oral infections.
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